What Are Pleural Plaques?
The pleura is the thin, two-layered membrane that lines the lungs (visceral pleura) and the inside of the chest wall (parietal pleura). Asbestos fibers, once inhaled, work their way through lung tissue and lodge in the pleura, triggering a chronic inflammatory response. Over decades, this inflammation causes localized areas of fibrosis — scar tissue that gradually calcifies into discrete, raised lesions called pleural plaques.
Pleural plaques are almost exclusively caused by asbestos exposure. They typically appear on the parietal pleura (the outer layer lining the chest wall and diaphragm) and are often bilateral — appearing on both sides of the chest. They are found on imaging in roughly 50% of people with significant occupational asbestos exposure who are followed for 20 or more years.
How They Are Diagnosed
Pleural plaques are generally asymptomatic — most people do not feel them and they are discovered incidentally on chest imaging. They appear as:
- Chest X-ray: Irregular calcified densities along the diaphragm and lateral chest wall (can be subtle; requires experienced radiologist reading)
- CT scan: The definitive modality — low-dose CT (LDCT) shows plaques with high sensitivity and can distinguish plaques from mesothelioma or other pleural disease
- B-reader X-ray reading: Physicians certified by NIOSH as "B-readers" are specifically trained to classify asbestos-related radiographic findings using the ILO classification system
Pleural Plaques vs. Other Asbestos Pleural Diseases
| Condition | Nature | Symptoms | Cancer Risk | Compensation |
|---|---|---|---|---|
| Pleural plaques | Calcified fibrotic patches on pleura | Usually none; mild dyspnea if extensive | Elevated but not directly causal | Varies by state and trust |
| Diffuse pleural thickening | Extensive fibrotic scarring of pleura | Dyspnea, restricted breathing, chest pain | Elevated | Generally compensable |
| Pleural effusion | Fluid accumulation in pleural space | Shortness of breath, chest heaviness | May be early mesothelioma sign | Requires workup for mesothelioma |
| Benign asbestos pleuritis | Acute pleural inflammation | Pleuritic chest pain, fever, effusion | Elevated | Generally compensable |
| Mesothelioma | Malignant pleural tumor | Progressive dyspnea, chest pain, weight loss | Is cancer — fatal | Major compensation available |
| Asbestosis | Parenchymal lung fibrosis | Progressive dyspnea, crackling breath sounds | Elevated for lung cancer | Compensable; varies by severity |
Do Pleural Plaques Cause Symptoms?
The vast majority of people with pleural plaques have no symptoms attributable to the plaques themselves. Plaques are discrete, focal lesions that generally do not affect pulmonary function unless they become very extensive or are accompanied by diffuse pleural thickening.
A small subset of people with extensive bilateral plaques may experience:
- Mild exertional dyspnea (shortness of breath with exertion)
- Slight reduction in lung compliance (lungs feel "stiffer")
- Chest tightness (usually when plaques are large or multiple)
Significant respiratory impairment from plaques alone is uncommon. When significant symptoms are present in someone with plaques, clinicians look carefully for co-existing asbestosis, diffuse pleural thickening, or early mesothelioma as the actual cause of the symptoms.
Why Pleural Plaques Matter Even Without Symptoms
The medical significance of pleural plaques is not the plaques themselves — it is what they tell you about your exposure history and future risk:
Definitive Proof of Asbestos Exposure
Pleural plaques are the most specific radiographic marker of prior asbestos exposure known. They essentially never occur without it. When a physician sees plaques on imaging, the diagnosis of significant prior asbestos exposure is effectively established — regardless of whether the patient recalls specific exposure events.
Elevated Lifetime Cancer Risk
People with documented pleural plaques have measurably higher lifetime rates of mesothelioma and lung cancer than the general population. The plaques are not themselves pre-cancerous, but they are a surrogate marker of the cumulative asbestos dose — and it is that dose that drives cancer risk. Studies show people with pleural plaques have approximately 5–9 times the general population risk of mesothelioma over their remaining lifetime.
Basis for Ongoing Surveillance
A pleural plaque finding triggers a lifetime medical monitoring protocol — typically annual low-dose CT scans — that has the potential to detect mesothelioma or lung cancer at an early, more treatable stage. See our asbestos screening guide for the full recommended surveillance protocol.
Monitoring Protocol for People with Pleural Plaques
Medical societies and pulmonologists who specialize in asbestos-related disease generally recommend the following for people diagnosed with pleural plaques:
- Baseline evaluation: Pulmonary function tests (spirometry, DLCO), baseline low-dose CT, full occupational and smoking history
- Annual low-dose CT (LDCT): Earlier detection of any evolving pleural disease or lung nodules; preferred over chest X-ray alone given superior sensitivity
- Annual pulmonary function tests: Monitor for declining lung function that could indicate asbestosis development
- Smoking cessation: Asbestos and tobacco smoke act synergistically — a smoker with asbestos exposure has approximately 50–90 times the lung cancer risk of a non-exposed non-smoker. Cessation is the single most impactful modifiable risk factor
- Symptom reporting: Any new dyspnea, chest pain, hemoptysis, or unexplained weight loss warrants prompt evaluation for mesothelioma or lung cancer
Legal Compensation for Pleural Plaques
Compensation eligibility for pleural plaques without a separate asbestos-related disease varies significantly by state:
- States allowing stand-alone pleural plaque claims: Some states recognize pleural plaques as a compensable injury in themselves, particularly with documented functional impairment. These include states like Georgia and Texas.
- States requiring separate disease: Many states — following the U.S. Supreme Court's direction in Norfolk & Western Railway Co. v. Ayers — require a plaintiff to have a separate asbestos-related disease to recover for fear of future cancer from pleural plaques.
- Asbestos trust funds: Most of the major asbestos bankruptcy trusts (Manville, Owens Corning, USG, National Gypsum) have specific pleural plaque claim categories that pay scheduled values ranging from a few thousand to tens of thousands of dollars, depending on the trust and the strength of the exposure evidence.
- Future disease claims: An attorney can advise whether to file now for pleural plaques or hold off to see if a more serious condition develops — preserving the ability to claim the full value of any future mesothelioma or asbestosis diagnosis.
If you have received a pleural plaque diagnosis, consulting a mesothelioma attorney is worthwhile even if you feel healthy. The consultation is free and can clarify your options before any statute of limitations issues arise.
Diagnosed with Pleural Plaques?
Get a free consultation with a mesothelioma attorney to understand your compensation options and protect your right to future claims.
Frequently Asked Questions
No — pleural plaques do not transform into mesothelioma. They are a different type of tissue change (benign fibrosis vs. malignant tumor) and there is no known mechanism by which plaques become cancerous. However, the same asbestos exposure that caused your plaques also increases your lifetime risk of developing mesothelioma, which would arise independently in the pleural mesothelial cells. The plaques are a warning sign about your exposure history and future risk, not a precancerous lesion itself.
There is no treatment to remove or reverse pleural plaques. Because the plaques themselves rarely cause significant symptoms, no specific treatment is needed for the plaques. Management focuses on surveillance — annual low-dose CT scans and pulmonary function tests to detect any progression or the development of a more serious condition. Smoking cessation is strongly recommended. Anti-inflammatory or other pharmacological approaches have not been shown to reduce plaque burden or prevent progression to more serious asbestos disease.